Follow
Andreas Clemens, MD, PhD
Andreas Clemens, MD, PhD
Medical Doctor and Researcher at Novartis Pharma AG
Verified email at novartis.com - Homepage
Title
Cited by
Cited by
Year
Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity
J Van Ryn, J Stangier, S Haertter, KH Liesenfeld, W Wienen, M Feuring, ...
Thrombosis and haemostasis 103 (06), 1116-1127, 2010
18762010
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
AM Gallagher, E Setakis, JM Plumb, A Clemens, TP van Staa
Thrombosis and haemostasis 106 (11), 968-977, 2011
5022011
Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor
J Stangier, A Clemens
Clinical and applied thrombosis/hemostasis 15 (1_suppl), 9S-16S, 2009
4452009
Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control
CL Morgan, P McEwan, A Tukiendorf, PA Robinson, A Clemens, ...
Thrombosis research 124 (1), 37-41, 2009
3912009
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork …
P Kirchhof, GYH Lip, IC Van Gelder, J Bax, E Hylek, S Kaab, U Schotten, ...
Europace 14 (1), 8-27, 2012
3512012
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice
MV Huisman, GYH Lip, HC Diener, M Brueckmann, J van Ryn, A Clemens
Thrombosis and haemostasis 107 (05), 838-847, 2012
3192012
Effective elimination of dabigatran by haemodialysis
D Khadzhynov, F Wagner, S Formella, E Wiegert, V Moschetti, T Slowinski, ...
Thrombosis and haemostasis 109 (04), 596-605, 2013
2582013
Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin
WG Eisert, N Hauel, J Stangier, W Wienen, A Clemens, J van Ryn
Arteriosclerosis, thrombosis, and vascular biology 30 (10), 1885-1889, 2010
2462010
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
FA Klok, V Hösel, A Clemens, WD Yollo, C Tilke, S Schulman, M Lankeit, ...
European Respiratory Journal 48 (5), 1369-1376, 2016
2342016
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference
P Kirchhof, G Breithardt, E Aliot, S Al Khatib, S Apostolakis, A Auricchio, ...
Europace 15 (11), 1540-1556, 2013
2162013
Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care …
M Yoon, PS Yang, E Jang, HT Yu, TH Kim, JS Uhm, JY Kim, JH Sung, ...
Thrombosis and haemostasis 119 (10), 1695-1703, 2019
2142019
Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)
MD Ezekowitz, R Nagarakanti, H Noack, M Brueckmann, C Litherland, ...
Circulation 134 (8), 589-598, 2016
2012016
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral …
MV Huisman, GYH Lip, HC Diener, SJ Dubner, JL Halperin, CS Ma, ...
American heart journal 167 (3), 329-334, 2014
1872014
Stroke prevention in atrial fibrillation—an Asian stroke perspective
HF Tse, YJ Wang, MA Ai-Abdullah, AB Pizarro-Borromeo, CE Chiang, ...
Heart rhythm 10 (7), 1082-1088, 2013
1792013
Prognostic value of codon 918 (ATG→ACG) RET proto‐oncogene mutations in sporadic medullary thyroid carcinoma
T Schilling, J Bürck, HP Sinn, A Clemens, HF Otto, W Höppner, C Herfarth, ...
International journal of cancer 95 (1), 62-66, 2001
1702001
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials
RJ Friedman, OE Dahl, N Rosencher, JA Caprini, AA Kurth, CW Francis, ...
Thrombosis research 126 (3), 175-182, 2010
1592010
Patient outcomes using the European label for dabigatran
GYH Lip, A Clemens, H Noack, J Ferreira, SJ Connolly, S Yusuf
Thrombosis and haemostasis 112 (05), 933-942, 2014
1552014
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate
NS Roskell, GYH Lip, H Noack, A Clemens, JM Plumb
Thrombosis and haemostasis 104 (12), 1106-1115, 2010
1532010
Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution
J Lüttges, A Reinecke-Lüthge, B Möllmann, MAOH Menke, A Clemens, ...
Virchows Archiv 435, 461-468, 1999
1441999
Brolucizumab: a newly developed anti-VEGF molecule for the treatment of neovascular age-related macular degeneration
R Tadayoni, L Sararols, G Weissgerber, R Verma, A Clemens, FG Holz
Ophthalmologica 244 (2), 93-101, 2021
1352021
The system can't perform the operation now. Try again later.
Articles 1–20